================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
September 20, 2006
TRANSGENOMIC, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 000-30975 911789357
------------------------ ------------------------ ----------------------
(State of Incorporation) (Commission File Number) (IRS Employer
Identification Number)
12325 Emmet Street, Omaha, Nebraska 68164
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
(402) 452-5400
----------------------------------------------------
(Registrant's telephone number, including area code)
Not applicable
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS.
On September 20, 2006, Michael A. Summers, our Chief Financial Officer
(Principal Financial Officer), submitted his resignation from that position
effective immediately in order to pursue another professional opportunity. No
interim replacement has been named for Mr. Summers. We have commenced a search
to replace Mr. Summers who has committed to assist us on an interim basis.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
TRANSGENOMIC, INC.
Dated: September 22, 2006
By: /s/ Craig J. Tuttle
-----------------------
Craig J. Tuttle
Principal and
Chief Executive Officer